| Date | Title | |
| Dec 06, 2012 | DURECT Announces Pricing of Public Offering of Common Stock |  |
| Nov 13, 2012 | DURECT to Participate in Upcoming Healthcare Conferences | |
| Nov 05, 2012 | DURECT Corporation Announces Third Quarter 2012 Financial Results and Update of Programs | |
| Oct 30, 2012 | DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call | |
| Aug 21, 2012 | DURECT to Participate in Upcoming Healthcare Conferences | |
| Aug 06, 2012 | DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs | |
| Aug 06, 2012 | DURECT Announces Intent to Submit NDA for POSIDUR™ for Post-Operative Analgesia | |
| Jul 26, 2012 | DURECT Corporation Invites You to Join its Second Quarter 2012 Earnings Conference Call | |
| May 03, 2012 | DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs | |
| May 03, 2012 | DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology | |
| Apr 25, 2012 | DURECT Corporation Invites You to Join its First Quarter 2012 Earnings Conference Call | |
| Mar 29, 2012 | DURECT Receives Back U.S. and Canadian Product Rights to POSIDUR™ | |
| Mar 01, 2012 | DURECT Corporation Announces Fourth Quarter and Year End 2011 Financial Results | |
| Feb 24, 2012 | DURECT Corporation Invites You to Join Its Fourth Quarter 2011 Earnings Conference Call | |
| Feb 23, 2012 | DURECT to Participate in Upcoming Healthcare Conferences | |
| Feb 07, 2012 | DURECT to Present at the BIO CEO & Investor Conference | |
| Jan 30, 2012 | DURECT Receives Back European Product Rights to POSIDUR™ | |
| Jan 05, 2012 | DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial) | |
